LEADER 02242nam  2200541   450 
001 9910787765103321
005 20230803031759.0
010   $a1-78084-246-5
010   $a1-78084-247-3
035   $a(CKB)2670000000481298
035   $a(EBL)1179650
035   $a(SSID)ssj0001599934
035   $a(PQKBManifestationID)16306260
035   $a(PQKBTitleCode)TC0001599934
035   $a(PQKBWorkID)14892433
035   $a(PQKB)11560980
035   $a(MiAaPQ)EBC1179650
035   $a(Au-PeEL)EBL1179650
035   $a(OCoLC)877767289
035   $a(EXLCZ)992670000000481298
100   $a20220517d2013      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aHypertension /$feditors, Ernesto L. Schiffrin and Rhian M. Touyz
205   $a1st ed.
210  1$aLondon, England :$cFuture Medicine Ltd.,$d[2013]
210  4$dİ2013
215   $a1 online resource (279 p.)
300   $aDescription based upon print version of record.
311   $a1-78084-248-1 
327   $aTitle page; Copyright page; Contents; Foreword. Update on hypertension, its genetics, epidemiology, mechanisms, clinical approaches and novel treatments; 1. Definition & diagnosis of hypertension; 2. Epidemiology of hypertension; 3. Genetics of hypertension; 4. Hemodynamics; 5. Role of the kidney in hypertension; 6. Renin-angiotensin-aldosterone system: new concepts; 7. Endothelin system: roles in hypertension; 8. CNS pathways contributing to sympathetic hyperactivity and hypertension; 9. Hypertensive vascular disease; 10. Hypertensive heart disease
327   $a11. Classification and diagnosis of hypertension12. Hypertension and cardiovascular risk; 13. Lifestyle modifications; 14. Antihypertensive agents; 15. Treatment of hypertension; 16. Clinical practice guidelines; 17. Resistant hypertension; Index
330   $aHypertension
606   $aHypertension
615  0$aHypertension.
676   $a616.132
702   $aSchiffrin$b Ernesto L.
702   $aTouyz$b Rhian M.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910787765103321
996   $aHypertension$9709611
997   $aUNINA